RHBDF2 Gene Tylosis with Esophageal Cancer Genetic Test
At DNA Labs UAE, we offer the RHBDF2 Gene Tylosis with Esophageal Cancer Genetic Test. This test helps in identifying the risk of developing esophageal cancer associated with the RHBDF2 gene. Here are the details of the test:
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Osteology Dermatology Immunology Disorders
Referring Doctor and Test Department
This test is recommended by dermatologists and falls under the Genetics department.
Pre Test Information
Prior to the RHBDF2 Gene Tylosis with Esophageal Cancer Genetic Test, a genetic counseling session is conducted to gather the clinical history of the patient. This includes information about family members affected by RHBDF2 Gene Tylosis with Esophageal Cancer NGS Genetic DNA Test gene RHBDF2. A pedigree chart is drawn to assess the inheritance pattern within the family.
Test Details
The RHBDF2 gene is associated with a condition called tylosis, which leads to thickening of the palms and soles of the feet. Individuals with tylosis have a higher risk of developing esophageal cancer. NGS (Next-Generation Sequencing) genetic testing is used to analyze multiple genes simultaneously. It helps in identifying genetic variations or mutations that may be linked to certain diseases or conditions, including tylosis and esophageal cancer.
By performing NGS genetic testing on the RHBDF2 gene, healthcare professionals can determine if there are any specific genetic variations or mutations present that may increase the risk of developing tylosis or esophageal cancer. This information is crucial for diagnosis, risk assessment, and potentially guiding treatment decisions.
It is important to note that genetic testing should be conducted in a clinical setting by healthcare professionals who are trained in genetics. The results of the test should be interpreted by a genetic counselor or medical geneticist to ensure accurate information and appropriate guidance for the individual being tested.
| Test Name | RHBDF2 Gene Tylosis with esophageal cancer Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for RHBDF2 Gene Tylosis with esophageal cancer NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RHBDF2 Gene Tylosis with esophageal cancer NGS Genetic DNA Test gene RHBDF2 |
| Test Details |
The RHBDF2 gene is associated with a condition called tylosis, which causes thickening of the palms and soles of the feet. People with tylosis have an increased risk of developing esophageal cancer. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. It can identify genetic variations or mutations that may be associated with certain diseases or conditions, including tylosis and esophageal cancer. By performing NGS genetic testing on the RHBDF2 gene, healthcare professionals can determine if there are any specific genetic variations or mutations present that may increase the risk of developing tylosis or esophageal cancer. This information can be used for diagnosis, risk assessment, and potentially guiding treatment decisions. It is important to note that genetic testing is typically performed in a clinical setting by healthcare professionals trained in genetics. The results of the test should be interpreted by a genetic counselor or medical geneticist to provide accurate information and appropriate guidance for the individual being tested. |
